CompoAtlas

Probiotic Supplement for IBS

Natural health product licensed in Canada

Other names
25B Probiotic, 25B Probiotic for IBS, IBS Probiotic, ProbioMAX Défense SCI, ProbioMAX IBS Defense, ProbioMAX IBS Relief, ProbioMAX IBS Support, ProbioMAX Soulagement SCI, ProbioMAX Soutien SCI, Probiotic 25B, Probiotic IBS Defense, Probiotic IBS Relief, Probiotic IBS Support, Probiotique Défense SCI, Probiotique Soulagement SCI, Probiotique Soutien SCI
Licence holder
Biena Inc.
NPN or DIN-HM
80118694
Status
Active licence
Licence date
17 May 2022
Revision date
12 October 2022
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lactobacillus acidophilus

Source : Lactobacillus acidophilus - Cellule entière

20 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : NCFM

20 Milliards d'UFCNot calculated

Non-medicinal ingredients

Phosphate de dipotassium, Dioxyde de silicium, Trehalose, Stéarate de magnésium, Cellulose microcristalline, Eau purifiée, L-Leucine, Hypromellose, Dioxyde de titane, Fécule de pomme de terre, Phosphate de potassium monobasique

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps alleviate/reduce moderate to severe abdominal pain in people with IBS/irritable bowel syndrome.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80118694

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line